Log in to save to my catalogue

Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric cor...

Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric cor...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5700396

Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpus

About this item

Full title

Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpus

Publisher

England: D.A. Spandidos

Journal title

Biomedical reports, 2017-11, Vol.7 (5), p.460-468

Language

English

Formats

Publication information

Publisher

England: D.A. Spandidos

More information

Scope and Contents

Contents

There is a lack of non-invasive screening modalities to diagnose chronic atrophic gastritis (CAG) and intestinal metaplasia (IM). Thus, the aim of the present study was to determine the sensitivity and specificity of serum pepsinogen I (PGI), PGI:II, the PGI:II ratio and gastrin-17 (G-17) in diagnosing CAG and IM, and the correlations between these...

Alternative Titles

Full title

Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpus

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5700396

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5700396

Other Identifiers

ISSN

2049-9434

E-ISSN

2049-9442

DOI

10.3892/br.2017.985

How to access this item